8-K
filed June 23, 2023, 7:59 PM ET
ticker KALA
CIK 0001479419
other material
confidence high
sentiment neutral
materiality 0.25
Kala shareholders approve equity plan increase, reject name change at annual meeting
KALA BIO, Inc.
- Approved A&R 2017 Equity Incentive Plan; adds 1.25M shares, extends term to June 2033.
- Elected C. Daniel Myers and Howard B. Rosen as Class III directors for three-year terms.
- Advisory vote on executive compensation passed (498,054 for, 57,912 against); frequency set every year.
- Proposal to rename to 'Kala Bio, Inc.' did not receive required votes; 1.15M for vs 11,194 against.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
KALA BIO, Inc. shareholders approved Election of C. Daniel Myers and Howard B. Rosen as Class III directors.
- Proposal
- director election
- Outcome
- passed
Exact text from the filing
The results of the stockholders’ vote with respect to the election of such Class III directors were as follows: Votes For Votes Withheld Broker Non- Votes C. Daniel Myers 544,974 26,177 594,432 Howard B. Rosen 550,334 20,817 594,432
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
KALA BIO, Inc. shareholders approved Non-binding advisory vote on frequency of future say-on-pay votes.
- Proposal
- say on pay frequency
- Outcome
- passed
Exact text from the filing
were as follows: Every One Year Every Two Years Every Three Years Votes Abstaining Broker Non- Votes 546,761 4,425 17,435 2,530 594,432
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
KALA BIO, Inc. shareholders rejected Amendment to Restated Certificate of Incorporation to change company name to Kala Bio, Inc..
- Proposal
- charter amendment
- Outcome
- failed
Exact text from the filing
were as follows: Votes For Votes Against Votes Abstaining Broker Non- Votes 1,151,465 11,194 2,924 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
KALA BIO, Inc. shareholders approved Approval of Amended and Restated 2017 Stock Option and Incentive Plan.
- Proposal
- equity plan
- Outcome
- passed
Exact text from the filing
were as follows: Votes For Votes Against Votes Abstaining Broker Non- Votes 495,640 71,992 3,519 594,432
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
KALA BIO, Inc. shareholders approved Non-binding advisory vote on compensation paid to named executive officers.
- Proposal
- say on pay
- Outcome
- passed
Exact text from the filing
2. The Company’s stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers. The results
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.